ロード中...
Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III Studies
Linezolid, an oxazolidinone antibiotic, has 100% oral bioavailability and favorable activities against gram-positive pathogens including multidrug-resistant staphylococci, enterococci, and pneumococci. Safety assessments were conducted for 2,046 linezolid-treated patients and 2,001 comparator drug-t...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC155822/ https://ncbi.nlm.nih.gov/pubmed/12760854 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.6.1824-1831.2003 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|